Drugs / BAY 86-5310
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00537836 | Oct 2007 → Dec 2008 | vasomotor rhinitis | Bayer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY 86-5310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00537836 ↗ |
| Known as | ZK 283197 | “BAY 86-5310 (ZK 283197)” NCT00537836 ↗ |
| Route | Oral | “administered orally once daily over 8 weeks” NCT00537836 ↗ |